Statewide
Vermont Department of Health, Office of Emergency Medical Services
Vermont Department of Health, Office of Emergency Medical Services (VT) carries 47 drugs across 212 dose entries in its current published protocol, effective 2025-01-01.
Drugs and doses47
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 63 |
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | page 54 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | page 54 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 54 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | page 54 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25–50 g | PO | not captured | standing | page 58 |
| Other | peds | per length-based resuscitation tape | PO | not captured | standing | page 58 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV/IO | not captured | standing | page 92 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 92 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 2.5 mg | NEB | not captured | standing | page 22 |
| Allergic reaction | peds | 2.5 mg | NEB | not captured | standing | page 22 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 28 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 28 |
| Cyanide poisoning | adult | 2.5 mg | NEB | not captured | standing | page 71 |
| Cyanide poisoning | peds | 2.5 mg | NEB | not captured | standing | page 71 |
| Hyperkalemia | adult | 10–20 mg | NEB | not captured | standing | page 41 |
| Hyperkalemia | peds | Weight-based | NEB | not captured | standing | page 41 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 93 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 93 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 83 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 83 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 77 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 80 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 80 |
| Nerve agent exposure | adult | 2 mg | IV/IO | not captured | standing | page 47 |
| Nerve agent exposure | peds | 0.05–0.1 mg/kg | IV/IO | not captured | standing | page 47 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 500–1000 mg | IV/IO | not captured | standing | page 80 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 80 |
| Hyperkalemia | adult | 500–1000 mg | IV/IO | not captured | standing | page 41 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 41 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2000 mg | IV/IO | not captured | standing | page 80 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 100 mg/kg | IV/IO | not captured | standing | page 80 |
| Hyperkalemia | adult | 2000 mg | IV/IO | not captured | standing | page 41 |
| Hyperkalemia | peds | 100 mg/kg | IV/IO | not captured | standing | page 41 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 10 mg | IV/IO/IM | not captured | standing | page 21 |
| Adrenal crisis | peds | 0.6 mg/kg | IV/IO/IM | not captured | standing | page 21 |
| Allergic reaction | adult | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 22 |
| Allergic reaction | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 22 |
| Asthma / bronchospasm | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 28 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 28 |
| Croup | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 29 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | page 37 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 37 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV | not captured | standing | page 158 |
| Agitation | adult | 5 mg | IV | not captured | standing | page 32 |
| Agitation | peds | 0.1 mg/kg | IV | not captured | standing | page 158 |
| Hyperthermia | adult | 2 mg | IV | not captured | standing | page 42 |
| Hyperthermia | peds | 0.2 mg/kg | IV | not captured | standing | page 42 |
| Hyperthermia | peds | 0.5 mg/kg | PR | not captured | standing | page 42 |
| Nerve agent exposure | adult | 10 mg | IM | not captured | standing | page 47 |
| Nerve agent exposure | adult | 5 mg | IV | not captured | standing | page 47 |
| Nerve agent exposure | peds | 0.3 mg/kg | IV | not captured | standing | page 47 |
| Procedural sedation | adult | 5 mg | IV/IO | not captured | standing | page 80 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 80 |
| Seizure | adult | 5–10 mg | IV | not captured | standing | page 62 |
| Seizure | peds | 0.1 mg/kg | IV | not captured | standing | page 62 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 22 |
| Allergic reaction | adult | 25–50 mg | PO | not captured | standing | page 22 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 22 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | page 22 |
| Dystonic reaction | adult | 25–50 mg | IV/IM | not captured | standing | page 46 |
| Dystonic reaction | peds | 0.5 mg/kg | IV/IM | not captured | standing | page 46 |
| Other | adult | 25 mg | PO | not captured | standing | page 46 |
| Other | peds | 6.25–25 mg | PO | not captured | standing | page 46 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | IM | not captured | standing | page 158 |
| Nausea / vomiting | adult | 0.625–1.25 mg | IV/IM | not captured | standing | page 46 |
| Other | adult | 5 mg | IV/IM | not captured | standing | page 158 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 22 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | page 22 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | page 80 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 83 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 83 |
| Croup | peds | 3 mg | NEB | not captured | standing | page 29 |
| Cyanide poisoning | adult | 3 mg | NEB | not captured | standing | page 71 |
| Cyanide poisoning | peds | 3 mg | NEB | not captured | standing | page 71 |
| Other | peds | 3 mg | NEB | not captured | standing | page 29 |
| Sepsis | peds | 0.1–1 mcg/kg | IV/IO | not captured | standing | page 65 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 25–100 mcg | IV | not captured | standing | page 54 |
| Mild to moderate pain | adult | 50–100 mcg | IM/IN | not captured | standing | page 54 |
| Mild to moderate pain | peds | 1 mcg/kg | IV | not captured | standing | page 54 |
| Mild to moderate pain | peds | 1 mcg/kg | IM/IN | not captured | standing | page 54 |
| Post-intubation sedation | adult | 50–100 mcg | IV/IO | not captured | standing | page 135 |
| Post-intubation sedation | peds | 1 mcg/kg | IV/IO | not captured | standing | page 135 |
| Procedural sedation | adult | 25–100 mcg | IV | not captured | standing | page 80 |
| Procedural sedation | peds | 1 mcg/kg | IV | not captured | standing | page 80 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–5 mg | IV/IO | not captured | standing | page 80 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5 mg | IV/IO | not captured | standing | page 80 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 37 |
| Hypoglycemia | peds | 0.5 mg | IM | not captured | standing | page 37 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IM | not captured | standing | page 158 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV/IO/IM | not captured | standing | page 21 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 21 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 71 |
| Cyanide poisoning | peds | 70 mg/kg | IV | not captured | standing | page 71 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 600 mg | PO | not captured | standing | page 54 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.5 mg | NEB | not captured | standing | page 22 |
| Allergic reaction | peds | 0.5 mg | NEB | not captured | standing | page 22 |
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 28 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 28 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 4 mg/kg | IM | not captured | standing | page 158 |
| Agitation | peds | 4 mg/kg | IM | not captured | standing | page 158 |
| Mild to moderate pain | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 55 |
| Mild to moderate pain | adult | 0.5 mg/kg | IM/IN | not captured | standing | page 55 |
| Mild to moderate pain | peds | 0.25 mg/kg | IV/IO | not captured | standing | page 55 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM/IN | not captured | standing | page 55 |
| Post-intubation sedation | adult | 1 mg/kg | IV/IO | not captured | standing | page 135 |
| Post-intubation sedation | peds | 1 mg/kg | IV/IO | not captured | standing | page 135 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 176 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | page 176 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 54 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 54 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20–50 mg | IO | not captured | standing | page 155 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 155 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV | not captured | standing | page 93 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 83 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 83 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg | PO | not captured | standing | page 32 |
| Agitation | adult | 1 mg | IV | not captured | standing | page 32 |
| Agitation | adult | 2 mg | IM | not captured | standing | page 158 |
| Agitation | peds | 0.25–2 mg | PO/SL | not captured | standing | page 194 |
| Hyperthermia | adult | 1 mg | IV | not captured | standing | page 42 |
| Hyperthermia | adult | 2 mg | IM | not captured | standing | page 42 |
| Hyperthermia | peds | 0.1 mg/kg | IV | not captured | standing | page 42 |
| Hyperthermia | peds | 0.1 mg/kg | IM | not captured | standing | page 42 |
| Nerve agent exposure | adult | 1 mg | IV | not captured | standing | page 47 |
| Nerve agent exposure | adult | 2 mg | IM | not captured | standing | page 47 |
| Nerve agent exposure | peds | 0.1 mg/kg | IV | not captured | standing | page 47 |
| Nerve agent exposure | peds | 0.1 mg/kg | IM | not captured | standing | page 47 |
| Post-intubation sedation | adult | 1–2 mg | IV/IO | not captured | standing | page 135 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 135 |
| Procedural sedation | adult | 1 mg | IV/IO | not captured | standing | page 80 |
| Procedural sedation | adult | 2 mg | IM | not captured | standing | page 80 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 80 |
| Procedural sedation | peds | 0.05 mg/kg | IM | not captured | standing | page 80 |
| Seizure | adult | 1–2 mg | IV | not captured | standing | page 62 |
| Seizure | peds | 0.1 mg/kg | IV | not captured | standing | page 62 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 28 |
| Asthma / bronchospasm | peds | 40 mg/kg | IV/IO | not captured | standing | page 28 |
| Seizure | adult | 4 g | IV/IO | not captured | standing | page 53 |
| Seizure | peds | 4 g | IV/IO | not captured | standing | page 53 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | page 83 |
| VF / pulseless VT | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 83 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | page 21 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 21 |
| Allergic reaction | adult | 1 mg/kg | IV | not captured | standing | page 22 |
| Allergic reaction | peds | 1 mg/kg | IV | not captured | standing | page 22 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | page 28 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 28 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 10 mg | IM | not captured | standing | page 46 |
| Nausea / vomiting | adult | 5–10 mg | IV | not captured | standing | page 46 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV | not captured | standing | page 93 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV/IN | not captured | standing | page 32 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 32 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 158 |
| Hyperthermia | adult | 2.5 mg | IV/IN | not captured | standing | page 42 |
| Hyperthermia | adult | 5 mg | IM | not captured | standing | page 42 |
| Hyperthermia | peds | 0.1 mg/kg | IV/IN | not captured | standing | page 42 |
| Hyperthermia | peds | 0.2 mg/kg | IM | not captured | standing | page 42 |
| Nerve agent exposure | adult | 2.5 mg | IV/IN | not captured | standing | page 47 |
| Nerve agent exposure | adult | 5 mg | IM | not captured | standing | page 47 |
| Nerve agent exposure | peds | 0.2 mg/kg | IV/IN | not captured | standing | page 47 |
| Nerve agent exposure | peds | 0.2 mg/kg | IM | not captured | standing | page 47 |
| Post-intubation sedation | adult | 2.5–5 mg | IV/IO | not captured | standing | page 135 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 135 |
| Procedural sedation | adult | 2.5 mg | IV/IO/IN | not captured | standing | page 80 |
| Procedural sedation | adult | 5 mg | IM | not captured | standing | page 80 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO/IN | not captured | standing | page 80 |
| Procedural sedation | peds | 0.05 mg/kg | IM | not captured | standing | page 80 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 62 |
| Seizure | adult | 5 mg | IV | not captured | standing | page 62 |
| Seizure | peds | 0.1 mg/kg | IV | not captured | standing | page 62 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 62 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2–5 mg | IV/IM | not captured | standing | page 54 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 54 |
| Procedural sedation | adult | 2–4 mg | IV | not captured | standing | page 80 |
| Procedural sedation | peds | 0.1 mg/kg | IV | not captured | standing | page 80 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 2 mg | IV/IO | not captured | standing | page 58 |
| Cardiac arrest | adult | 4 mg | IN | not captured | standing | page 58 |
| Cardiac arrest | peds | 4 mg | IN | not captured | standing | page 58 |
| Respiratory distress | peds | 0.1 mg/kg | IV/IO/IM/IN/SQ | not captured | standing | page 26 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM/PO/ODT | not captured | standing | page 46 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM/PO/ODT | not captured | standing | page 46 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15–30 g | PO | not captured | standing | page 37 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | page 37 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 51 |
Phenylephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 39 |
| Other | peds | 2 spray | IN | not captured | standing | page 39 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 1–2 g | IV | not captured | standing | page 47 |
| Nerve agent exposure | peds | 25–50 mg/kg | IV | not captured | standing | page 47 |
Prochlorperazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 10 mg | IM | not captured | standing | page 46 |
| Nausea / vomiting | adult | 5–10 mg | IV | not captured | standing | page 46 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 drop | not captured | not captured | standing | page 103 |
| Other | peds | 2 drop | not captured | not captured | standing | page 103 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | page 176 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | page 176 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 1 mEq/kg | IV/IO | not captured | standing | page 100 |
| Crush injury | peds | 1 mEq/kg | IV/IO | not captured | standing | page 100 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 41 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 41 |
| Other | adult | 1–2 mEq/kg | IV/IO | not captured | standing | page 84 |
| Other | peds | 1–2 mEq/kg | IV/IO | not captured | standing | page 84 |
| Tricyclic overdose | adult | 1–2 mEq/kg | IV/IO | not captured | standing | page 58 |
| Tricyclic overdose | peds | 1–2 mEq/kg | IV/IO | not captured | standing | page 58 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 176 |
| RSI induction | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 176 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 drop | TOP | not captured | standing | page 103 |
| Other | peds | 2 drop | TOP | not captured | standing | page 103 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV/IO | not captured | standing | page 53 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 40 unit | IV/IO | not captured | standing | page 267 |
| Hypotension / shock | adult | 0.02–0.1 unit | IV | not captured | standing | page 267 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 176 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 176 |